bullish
PYC-003 Shows Positive Preclinical Safety and Efficacy Data in Mice and NHPs
This morning, PYC released preclinical data in two species (mice, non-human primate) for its PYC-003 program in ADPKD (autosomal dominant polycystic kidney disease).
What is covered in the Full Insight:
- Introduction to PYC-003 and Preclinical Data Results
- Safety and Pharmacokinetics in Non-Human Primates
- Mechanism of Action and PC1 Protein Upregulation
- Next Steps: Human Trials and Regulatory Pathway
- Conclusion and Analyst's Investment Recommendation
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 16-minute read)
Discussions
(Paid Plans Only)
x